IFAPP International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine

Ethics in Data-driven Research: WMA Declaration of Taipei on Health Databases and Biobanks Part 3: Opinions from Patients and the Public

The WMA’s Declaration of Taipei (DoT), now in the revision process, is important for patients and the public as it […]

EU In Vitro Diagnostic Regulation (IVDR) Implementation. State of Play and Challenges

The webinar will be given by Todor Darakchiev, M. Pharm., Head of Division Medical Devices Department, Market Supervision and Inspections, […]

Opportunities and Challenges inImplementing the European AI Regulation: Overview of Content and Status of Implementation from a Regulatory Perspective

Regulation (EU) 2024/1689, commonly referred to as the “EU AI Act,” is considered the world’s first comprehensive regulation of artificial […]

Ethics in Data-driven Research: WMA Declaration of Taipei on Health Databases and Biobanks Part 2: Solidarity and morality of research participation: Asian experiences and perspectives

The 2024 revision of the Declaration of Helsinki included the Declaration of Taipei (DoT) for the secondary use of data […]

Professional Identity in Pharmaceutical Medicine / Medicines Development

Join us for an insightful webinar exploring the evolving professional identity within Pharmaceutical Medicine and medicines development. Programme Don’t miss […]

Practical challenges of implementing ICH-GCP(R3) in your clinical trials

Please note that this webinar, a special virtual Workshop following the webinar of 30th June 2025 on the ICH – […]

ICH – GCP Revision Webinar

Good Clinical Practice (GCP) is the international scientific and ethical standard for the conduct of interventional clinical trials. The ICH […]

Ethics in Data-driven Research: WMA Declaration of Taipei on Health Databases and Biobanks

The 2024 revision of the Declaration of Helsinki included for the first time the Declaration of Taipei (DoT) for secondary […]